These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 180375)

  • 1. [Hormone therapy of breast cancer].
    Maass H
    Med Welt; 1976 May; 27(21):1047-51. PubMed ID: 180375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)].
    Maass H; Jonat W
    Arch Geschwulstforsch; 1981; 51(7):623-9. PubMed ID: 7337544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human breast cancer and estrogen receptor.
    Engelsman E; Korsten CB; Persijn JP; Cleton FJ
    Arch Chir Neerl; 1973; 25(4):393-7. PubMed ID: 4771976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer of the breast. Endocrine and hormonal therapy.
    Kardinal CG; Donegan WL
    Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine treatment of gynecologic carcinomas].
    Maass H
    Fortschr Med; 1975 Oct; 93(28):1313-5. PubMed ID: 58826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal therapy of metastizing breast cancer].
    von Werder K
    Med Klin; 1976 Feb; 71(8):313-21. PubMed ID: 56699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical therapy of the metastasizing breast neoplasm].
    Hartenstein R; Ehrhart H; Pape W
    Fortschr Med; 1977 May; 95(19):1305-12. PubMed ID: 863373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone therapy of breast cancer].
    Petit JC
    J Med Strasb; 1972 Oct; 2(10):655-9. PubMed ID: 12333027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of patients with carcinoma of the breast to hormonal therapy and combination chemotherapy.
    Henderson MD; Buroker TR; Samson MK; Mood DW; Baker LH; Vaitkevicius VK
    Surg Gynecol Obstet; 1975 Aug; 141(2):232-4. PubMed ID: 1154233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptors in hormone-dependent breast cancers.
    Jensen EV
    Cancer Res; 1975 Nov; 35(11 Pt. 2):3362-4. PubMed ID: 172222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of endocrine therapy.
    Pritchard KI; Sutherland DJ
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):765-805. PubMed ID: 2481670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of GnRH analogues in early and advanced breast carcinomas].
    Ségura C; Avenin D; Gligorov J; Selle F; Estéso A; Beerblock K; Emile G; Do Huyen N; Lotz JP
    Gynecol Obstet Fertil; 2005 Nov; 33(11):914-9. PubMed ID: 16246613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
    Winer EP; Hudis C; Burstein HJ; Wolff AC; Pritchard KI; Ingle JN; Chlebowski RT; Gelber R; Edge SB; Gralow J; Cobleigh MA; Mamounas EP; Goldstein LJ; Whelan TJ; Powles TJ; Bryant J; Perkins C; Perotti J; Braun S; Langer AS; Browman GP; Somerfield MR
    J Clin Oncol; 2005 Jan; 23(3):619-29. PubMed ID: 15545664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.